The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...

Scientists used IBM's R2 Heron quantum processor to predict the secondary protein structure of a 60-nucleotide-long mRNA ...

At two gene loci the researchers studied, increased looping in the absence of ORC2 isolated a known gene enhancer from the ...

A new discovery about mutations in a gene that causes ALS may allow researchers to design targeted therapies, a study found.

It may be time to rethink certain genetic mutations associated with two devastating neurodegenerative disorders—amyotrophic ...

Shifting from its pandemic response origins, the market is diversifying into new vaccines and oncology. Asset-light biotechs fuel this growth, making ...

Origin-recognition complex, or ORC, plays an unexpectedly broad role in the regulation of human cell gene expression, according to ...

Scientists once dismissed the theory that traits acquired during life could be inherited, but with new evidence and ...

Researchers at San Diego State University and Michigan State University are shedding new light on how viruses meticulously ...

STONY BROOK, NY / ACCESS Newswire / August 14, 2025 /Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a biotechnology company focused on providing nucleic acid production ...

RNA drugs might be able to protect against a huge range of viruses by turning on key parts of our innate defences against infection ...

STONY BROOK, NY / / August 14, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a biotechnology company focused on providing nucleic acid production solutions ...